Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...
Ben Medrano, MD, and Michael J Verbora, MD, MBA discuss what patient populations are benefiting most from intravenous (IV) ketamine treatment and what populations could be potentially harmed by the...
In this video, Charles Conway, MD, summarizes new research supporting the use of nitrous oxide for the treatment of treatment-resistant major depression (TRMD).
In part 2 of this video, Charles Conway, MD, covers possible side effects of the use of nitrous oxide for the treatment of treatment-resistant major depression , and next steps for continued research....
In this video, researcher Jennifer Watt, MD, PhD, discusses her study that found non-drug interventions may be more effective than drug interventions for reducing symptoms of depression in people with...
In this video, Valeria Mondelli, MD, PhD, discusses her research which found that in patients with treatment-resistant depression and low-grade peripheral inflammation, minocycline, a widely used...
The polygenic risk score (PRS) for depression may help identify major depressive disorder when considered along with other risk factors for depression, researchers recently reported in JAMA Psychiatry.
...
In this video, Dr. Robert Naviaux, MD, PhD, discusses his research that found the risk of future depression was determined in large part by a mitochondrial nexus in metabolism, which could be a new...
